相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis
Humam Kadara et al.
CLINICAL CANCER RESEARCH (2011)
A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer
Xiaoyang Luo et al.
JOURNAL OF PROTEOMICS (2011)
Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis
W. C. S. Cho et al.
BRITISH JOURNAL OF CANCER (2010)
Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non-Small-Cell Lung Cancer
Zhibin Hu et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Nuclear Receptor Expression Defines a Set of Prognostic Biomarkers for Lung Cancer
Yangsik Jeong et al.
PLOS MEDICINE (2010)
Perspectives of targeted mass spectrometry for protein biomarker verification
Ruth Huettenhain et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
Relapse-Related Molecular Signature in Lung Adenocarcinomas Identifies Patients With Dismal Prognosis
Shuta Tomida et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Confirmation of Gene Expression - Based Prediction of Survival in Non-Small Cell Lung Cancer
Nancy L. Guo et al.
CLINICAL CANCER RESEARCH (2008)
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
Kerby Shedden et al.
NATURE MEDICINE (2008)
Molecular origins of cancer: Lung cancer
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Localized-Statistical Quantification of Human Serum Proteome Associated with Type 2 Diabetes
Rong-Xia Li et al.
PLOS ONE (2008)
A five-gene signature and clinical outcome in non-small-cell lung cancer
Hsuan-Yu Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
被撤回的出版物: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer (Retracted Article. See vol 356, pg 201, 2007)
Anil Potti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
分享论文
